• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday

    5/16/24 8:20:20 AM ET
    $ACN
    $ADI
    $BABA
    $FATE
    Real Estate
    Real Estate
    Semiconductors
    Technology
    Get the next $ACN alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

    • Stifel cut the price target for Spire Global, Inc. (NYSE:SPIR) from $24 to $20. Stifel analyst Erik Rasmussen maintained a Buy rating. Spire Global shares fell 6.8% to close at $11.34 on Wednesday. See how other analysts view this stock.
    • Oppenheimer boosted the price target for Analog Devices, Inc. (NASDAQ:ADI) from $215 to $245. Oppenheimer analyst Rick Schafer maintained an Outperform rating. Analog Devices shares rose 1.8% to close at $215.75 on Wednesday. See how other analysts view this stock.
    • Goldman Sachs cut Sagimet Biosciences Inc.. (NASDAQ:SGMT) price target from $27 to $23. Goldman Sachs analyst Andrea Tan maintained a Buy rating. Sagimet Biosciences shares rose 5.5% to close at $4.62 on Wednesday. See how other analysts view this stock.
    • HC Wainwright & Co. slashed the price target for Fate Therapeutics, Inc. (NASDAQ:FATE) from $7 to $5. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Neutral rating. Fate Therapeutics shares gained 0.5% to close at $4.24 on Wednesday. See how other analysts view this stock.
    • Baird cut Accenture plc (NYSE:ACN) price target from $372 to $345. Baird analyst David Koning maintained a Neutral rating. Accenture shares gained 0.5% to close at $308.52 on Wednesday. See how other analysts view this stock.
    • Needham boosted Zebra Technologies Corporation (NASDAQ:ZBRA) price target from $352 to $370. Needham analyst James Ricchiuti maintained a Buy rating. Zebra Technologies shares rose 0.9% to close at $323.87 on Wednesday. See how other analysts view this stock.
    • Mizuho raised the price target for Portland General Electric Company (NYSE:POR) from $42 to $45. Mizuho analyst Anthony Crowdell maintained a Neutral rating. Portland General Electric shares rose 0.8% to close at $44.64 on Wednesday. See how other analysts view this stock.
    • B of A Securities raised Alibaba Group Holding Limited (NYSE:BABA) price target from $99 to $103. B of A Securities analyst Eddie Leung maintained a Buy rating. Alibaba shares gained 1.9% to close at $80.99 on Wednesday. See how other analysts view this stock.
    • Keybanc raised monday.com Ltd. (NASDAQ:MNDY) price target from $275 to $280. Keybanc analyst Jackson Ader maintained an Overweight rating. monday.com shares jumped 21.4% to close at $220.72 on Wednesday. See how other analysts view this stock.
    • Truist Securities cut Occidental Petroleum Corporation (NYSE:OXY) price target from $84 to $69. Truist Securities analyst Neal Dingmann downgraded the stock from Buy to Hold. Occidental Petroleum shares climbed 0.5% to close at $63.38 on Wednesday. See how other analysts view this stock.

    Check This Out: Wall Street’s Most Accurate Analysts Say Hold These 3 Real Estate Stocks Delivering High-Dividend Yields

    Get the next $ACN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACN
    $ADI
    $BABA
    $FATE

    CompanyDatePrice TargetRatingAnalyst
    Analog Devices Inc.
    $ADI
    2/12/2026$375.00Equal Weight → Overweight
    Barclays
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    monday.com Ltd.
    $MNDY
    2/10/2026$90.00Outperform → Neutral
    Robert W. Baird
    Sagimet Biosciences Inc.
    $SGMT
    2/3/2026$27.00Buy
    Guggenheim
    Sagimet Biosciences Inc.
    $SGMT
    1/28/2026$8.00Equal Weight
    Barclays
    Accenture plc
    $ACN
    1/22/2026$313.00Buy
    Berenberg
    Occidental Petroleum Corporation
    $OXY
    1/21/2026Equal Weight
    Barclays
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    More analyst ratings

    $ACN
    $ADI
    $BABA
    $FATE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Klesse William R bought $194,900 worth of shares (5,000 units at $38.98), increasing direct ownership by 2% to 218,913 units (SEC Form 4)

    4 - OCCIDENTAL PETROLEUM CORP /DE/ (0000797468) (Issuer)

    12/17/25 5:00:08 PM ET
    $OXY
    Oil & Gas Production
    Energy

    Director Dhanasekaran Satish bought $233,118 worth of shares (1,000 units at $233.12), increasing direct ownership by 42% to 3,356 units (SEC Form 4)

    4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)

    11/20/25 4:29:15 PM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    Director Gustafsson Anders bought $1,000,243 worth of shares (3,227 units at $309.96), increasing direct ownership by 2% to 204,903 units (SEC Form 4)

    4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)

    2/25/25 4:41:28 PM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    $ACN
    $ADI
    $BABA
    $FATE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Happel David sold $64,865 worth of Series A Common Stock (12,101 units at $5.36), decreasing direct ownership by 2% to 677,621 units (SEC Form 4)

    4 - Sagimet Biosciences Inc. (0001400118) (Issuer)

    2/12/26 4:08:51 PM ET
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Chauche Thierry sold $7,033 worth of Series A Common Stock (1,312 units at $5.36), decreasing direct ownership by 8% to 15,688 units (SEC Form 4)

    4 - Sagimet Biosciences Inc. (0001400118) (Issuer)

    2/12/26 4:07:20 PM ET
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Martins Eduardo Bruno sold $19,511 worth of Series A Common Stock (3,640 units at $5.36), decreasing direct ownership by 3% to 103,296 units (SEC Form 4)

    4 - Sagimet Biosciences Inc. (0001400118) (Issuer)

    2/12/26 4:06:10 PM ET
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACN
    $ADI
    $BABA
    $FATE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by monday.com Ltd.

    SCHEDULE 13G - monday.com Ltd. (0001845338) (Subject)

    2/13/26 5:32:38 PM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by Zebra Technologies Corporation

    10-K - ZEBRA TECHNOLOGIES CORP (0000877212) (Filer)

    2/12/26 4:07:48 PM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    SEC Form 13F-HR filed by Alibaba Group Holding Limited

    13F-HR - Alibaba Group Holding Ltd (0001577552) (Filer)

    2/12/26 4:00:12 PM ET
    $BABA
    Real Estate

    $ACN
    $ADI
    $BABA
    $FATE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Portland General Electric revises date and time for earnings release and conference call to Tuesday, February 17 at 8am ET

    PORTLAND, Ore., Feb. 16, 2026 /PRNewswire/ -- Portland General Electric Company (NYSE: POR) announced today a revised date to host an analyst conference call and webcast to review its fourth quarter and full-year 2025 financial results of Tuesday, February 17, 2026 at 8:00 a.m. ET. This conference call will replace the previously scheduled conference call on February 20, 2026. Portland General Electric plans to release its fourth quarter and full-year 2025 earnings summary before financial markets open in the United States on February 17. The conference call will be hosted by Maria Pope, President and CEO; Joe Trpik, Senior Vice President of Finance and CFO; and Nick White, Manager of Invest

    2/16/26 4:00:00 PM ET
    $POR
    Electric Utilities: Central
    Utilities

    IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

    New York, USA, Feb. 16, 2026 (GLOBE NEWSWIRE) -- IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The iPSC-derived NK cells clinical trial analysis report delivers important insights into ongoing research of 15+ pipeline iPSC-derived NK cells drugs, clinical strategies, upcoming therapeutics, and commercial analysis. DelveInsight's 'IPSC-derived NK Cells Pipeline Insight 2026' report provides comprehensive global coverage of pipeline therapies for IPSC-derived NK cells across various stages of clinical development. The report offers an in-depth analysis of key trends, emerging therapies, and competitiv

    2/16/26 1:00:00 PM ET
    $FATE
    $IPSC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Portland General Electric declares dividend

    PORTLAND, Ore., Feb. 13, 2026 /PRNewswire/ -- On February 13, 2026, the board of directors of Portland General Electric Company (NYSE:POR) declared a quarterly common stock dividend of $0.525 per share. The company's dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term. The quarterly dividend is payable on or before April 15, 2026, to shareholders of record at the close of business on March 23, 2026. About Portland General Electric CompanyPortland General Electric (NYSE:POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an

    2/13/26 7:08:00 PM ET
    $POR
    Electric Utilities: Central
    Utilities

    $ACN
    $ADI
    $BABA
    $FATE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analog Devices upgraded by Barclays with a new price target

    Barclays upgraded Analog Devices from Equal Weight to Overweight and set a new price target of $375.00

    2/12/26 8:03:47 AM ET
    $ADI
    Semiconductors
    Technology

    Monday.com downgraded by Loop Capital with a new price target

    Loop Capital downgraded Monday.com from Buy to Hold and set a new price target of $80.00

    2/10/26 8:00:13 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    Monday.com downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Monday.com from Outperform to Neutral and set a new price target of $90.00

    2/10/26 8:00:13 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    $ACN
    $ADI
    $BABA
    $FATE
    Leadership Updates

    Live Leadership Updates

    View All

    Accenture Appoints Rachel Frey Chief Communications Officer

    Accenture (NYSE:ACN) today announced the appointment of Rachel Frey as chief communications officer, a newly created role. Effective immediately, Frey reports to Accenture Chair and CEO Julie Sweet and joins Accenture's Global Management Committee. Frey brings more than two decades of experience in communications. In her most recent role as Accenture's global head of Corporate Communications, she strengthened the company's relationships with external audiences; developed and elevated an enhanced earned communications strategy that has strategically positioned Accenture and its leaders at the forefront of AI reinvention across every major sector and region around the world; and leveraged d

    2/11/26 10:43:00 AM ET
    $ACN
    Real Estate

    Analog Devices Appoints Yoky Matsuoka to its Board of Directors

    WILMINGTON, Mass., Jan. 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ:ADI) today announced the appointment of Dr. Yoky Matsuoka to its Board of Directors as an independent director and member of the Board's Corporate Development Committee effective January 20, 2026. Dr. Matsuoka's appointment expands the Board to 11 members. Dr. Matsuoka serves as an executive officer of Panasonic Holdings, a global leader in the development of innovative technologies and solutions for wide-ranging applications across industries. In this role, she is responsible for global innovation a

    1/23/26 7:03:00 AM ET
    $ADI
    Semiconductors
    Technology

    Zebra Technologies Appoints Melissa Luff Loizides as Chief People Officer

    Strategic HR executive with more than 25 years of experience to continue to support business growth Zebra Technologies Corporation (NASDAQ:ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, announced that Melissa Luff Loizides has been named the company's next Chief People Officer (CPO), effective Jan. 1, 2026. The current CPO, Jeff Schmitz plans to step down on Dec. 31, 2025 and lead the integration of the Elo acquisition through the second quarter of 2026, after which he will retire. This leadership transition reflects Zebra's focus on strategic succession planning and commitment to the successful integration of Elo. This press release featur

    11/24/25 8:30:00 AM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    $ACN
    $ADI
    $BABA
    $FATE
    Financials

    Live finance-specific insights

    View All

    Portland General Electric revises date and time for earnings release and conference call to Tuesday, February 17 at 8am ET

    PORTLAND, Ore., Feb. 16, 2026 /PRNewswire/ -- Portland General Electric Company (NYSE: POR) announced today a revised date to host an analyst conference call and webcast to review its fourth quarter and full-year 2025 financial results of Tuesday, February 17, 2026 at 8:00 a.m. ET. This conference call will replace the previously scheduled conference call on February 20, 2026. Portland General Electric plans to release its fourth quarter and full-year 2025 earnings summary before financial markets open in the United States on February 17. The conference call will be hosted by Maria Pope, President and CEO; Joe Trpik, Senior Vice President of Finance and CFO; and Nick White, Manager of Invest

    2/16/26 4:00:00 PM ET
    $POR
    Electric Utilities: Central
    Utilities

    Portland General Electric declares dividend

    PORTLAND, Ore., Feb. 13, 2026 /PRNewswire/ -- On February 13, 2026, the board of directors of Portland General Electric Company (NYSE:POR) declared a quarterly common stock dividend of $0.525 per share. The company's dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term. The quarterly dividend is payable on or before April 15, 2026, to shareholders of record at the close of business on March 23, 2026. About Portland General Electric CompanyPortland General Electric (NYSE:POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an

    2/13/26 7:08:00 PM ET
    $POR
    Electric Utilities: Central
    Utilities

    Zebra Technologies Announces Fourth-Quarter and Full-Year 2025 Results

    Fourth-Quarter Financial Highlights Net sales of $1,475 million; year-over-year increase of 10.6% $76 million exit and restructuring charges for actions to increase focus and productivity Net income of $70 million and net income per diluted share of $1.39, year-over-year decrease of 57.1% and 55.7%, respectively Non-GAAP diluted EPS increased 8.3% year-over-year to $4.33 Adjusted EBITDA increased 10.5% year-over-year to $326 million $303 million of share repurchases towards its previously announced $500 million 12-month commitment Zebra Technologies Corporation (NASDAQ:ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today

    2/12/26 6:30:00 AM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    $ACN
    $ADI
    $BABA
    $FATE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sagimet Biosciences Inc.

    SC 13G/A - Sagimet Biosciences Inc. (0001400118) (Subject)

    11/14/24 7:55:59 PM ET
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Fate Therapeutics Inc.

    SC 13G/A - FATE THERAPEUTICS INC (0001434316) (Subject)

    11/14/24 7:50:18 PM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Sagimet Biosciences Inc.

    SC 13G - Sagimet Biosciences Inc. (0001400118) (Subject)

    11/14/24 5:05:18 PM ET
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care